European journal of preventive cardiology
May 1, 2022
Victor Hugo Lucas Neves
Abstract Funding Acknowledgements Type of funding sources: None. Background It has been well established that the prevalence of depression is higher in people with cardiovascular disease (CVD), leading to a significantly worse prognosis after coronary syndromes. A recent individual patient data meta-analysis has shown that Mindfulness-Based Interventions (MBIs) such as Mindfulness-Based...
Journal of Spinal Cord Medicine
May 1, 2022
Jeanne M Zanca, Christine Gilchrist, Caroline E Ortiz et al.
To assess the feasibility and potential benefits of clinical meditation and imagery (CMI) for people with chronic spinal cord injury (SCI) and chronic pain. Pilot randomized, controlled trial. Outpatients with SCI in the United States. 24 adults with chronic SCI (>1 year) and a >3 month history of pain rated ≥4/10 on average over the last week. 4-week program of once-weekly 2-hour group...
IBRO Neuroscience Reports
May 1, 2022
Anh An, Huy Hoang, Long Trang et al.
Financial constraints usually hinder students, especially those in low-middle income countries (LMICs), from seeking mental health interventions. Hence, it is necessary to identify effective, affordable and sustainable counter-stress measures for college students in the LMICs context. This study examines the sustained effects of mindfulness practice on the psychological outcomes and brain...
Journal of Psychiatric Research
May 1, 2022
Tuyen T. Le, Isabel Pazos Cordero, Muhammad Youshay Jawad et al.
82 citations
While ketamine has been used clinically over the past decades, it has only been recently shown to be a promising therapy for treatment-resistant depression (TRD). However, ketamine and related dissociative agents may also be misused recreationally, creating significant concerns for abuse liability when prescribed for depression. Although the abuse potential of ketamine is widely recognized,...
Journal of Biotechnology and Strategic Health Research
April 30, 2022
Muhammet Sevi̇ndi̇k, Şerif Bora Nazli, Orhan Murat Koçak
Introduction: The relationship between anxiety and dissociative symptoms is frequently mentioned, but dissociative symptoms are not seen in all patients with anxiety disorder. The aim of this study is to investigate the relationship between dissociative symptoms and temperament-character features in patients with anxiety disorders. Methods: The study sample consisted of 75 patients diagnosed...
Cureus
April 30, 2022
Neethu K Nandan, Puneet K Soni, Ajay K. Parsaik et al.
11 citations
Borderline personality disorder (BPD) is an extremely disabling condition that affects almost every dimension of a patient's life. The S-enantiomer of ketamine (esketamine) was approved by the Food and Drug Administration (FDA) in 2019 in conjunction with an oral antidepressant for the management of treatment-resistant depression (TRD) in adults. Our patient is a 27-year-old female with a...
European Journal of Futures Research
April 30, 2022
Claudia Schwarz-Plaschg
36 citations
Abstract After decades of criminalization, psychedelic substances such as psilocybin and LSD are experiencing their comeback in science and Western culture more broadly. While psychedelic plants and fungi have a long history of use in Indigenous cultures, the Western prohibitionist reality instantiated around 1970 has stigmatized psychedelics as medically useless and a threat to society. Yet...
Journal of Medical Internet Research
April 29, 2022
Bin Chen, Ting Yang, Lei Xiao et al.
Background Mobile mindfulness meditation (MMM) is a mindfulness meditation intervention implemented using mobile devices such as smartphones and apps. MMM has been used to help manage the mental health of university students. Objective This study aims to evaluate the effectiveness of MMM on the mental health of university students in the areas of stress, anxiety, depression, mindfulness,...
April 28, 2022
Manoj K. Doss, Frederick S. Barrett, Philip R. Corlett
1 citation
preprint
Here we raise issues in Daws et al. (2022) published in Nature Medicine.
ChemBioChem
April 28, 2022
Claudius Lenz, Sebastian Dörner, Felix Trottmann et al.
26 citations
Abstract Psilocybin ( 1 ) is the major alkaloid found in psychedelic mushrooms and acts as a prodrug to psilocin ( 2 , 4‐hydroxy‐ N , N ‐dimethyltryptamine), a potent psychedelic that exerts remarkable alteration of human consciousness. In contrast, the positional isomer bufotenin ( 7 , 5‐hydroxy‐ N , N ‐dimethyltryptamine) differs significantly in its reported pharmacology. A series of...